Topics

AstraZeneca joins forces with Silence to develop siRNA therapeutics

10:58 EDT 25 Mar 2020 | Manufacturing Chemist

Collaboration with Silence Therapeutics has been agreed to develop small interfering RNA therapeutics that act inside the cell to influence protein production

Original Article: AstraZeneca joins forces with Silence to develop siRNA therapeutics

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca joins forces with Silence to develop siRNA therapeutics"

Quick Search

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...